Quadrant Capital Group’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-105
Closed -$671 1431
2025
Q1
$671 Buy
105
+86
+453% +$829 ﹤0.01% 2620
2024
Q4
$226 Hold
19
﹤0.01% 2695
2024
Q3
$527 Hold
19
﹤0.01% 2670
2024
Q2
$454 Hold
19
﹤0.01% 2634
2024
Q1
$335 Hold
19
﹤0.01% 2666
2023
Q4
$300 Hold
19
﹤0.01% 2649
2023
Q3
$164 Sell
19
-276
-94% -$1.96K ﹤0.01% 2652
2023
Q2
$2.33K Buy
+295
New +$2.05K ﹤0.01% 2381
2023
Q1
Sell
-62
Closed -$731 2718
2022
Q4
$731 Sell
62
-130
-68% -$1.49K ﹤0.01% 2586
2022
Q3
$2K Buy
+192
New +$2.33K ﹤0.01% 2333

Other funds holding ASPN

Quadrant Capital Group's ASPN Position: Q2 2025 in Review

Quadrant Capital Group sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 105 shares — an estimated $671 sold.

Quadrant Capital Group first reported a position in ASPN in Q3 2022 and held it in 10 quarters. The position peaked at $2.33K in Q2 2023. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Quadrant Capital Group reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Quadrant Capital Group sold 105 Aspen Aerogels shares in Q2 2025, an estimated $671.
  • Quadrant Capital Group first reported a position in Aspen Aerogels in Q3 2022 and held it in 10 quarters.
  • Quadrant Capital Group's Aspen Aerogels position peaked at $2.33K in Q2 2023.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Quadrant Capital Group's 13F filing for Q2 2025, filed 13 Aug 2025.